Cybin Inc. Common Stock (HELP) is a publicly traded the market company. As of May 21, 2026, HELP trades at $4.39 with a market cap of $221.53M and a P/E ratio of 0.00. HELP moved +3.95% today. Year to date, HELP is -43.86%; over the trailing twelve months it is flat. Its 52-week range spans $4.15 to $8.97. Analyst consensus is strong buy with an average price target of $48.75. Rallies surfaces HELP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BetterLife Pharma Expands Board to Six Members With Doug Drysdale as Executive Chairman: BetterLife Pharma named Doug Drysdale as Executive Chairman and Director, effective May 13, 2026, increasing its board to six members. Drysdale brings over two decades of pharmaceutical leadership experience and will drive corporate strategy and governance enhancements.
| Metric | Value |
|---|---|
| Price | $4.39 |
| Market Cap | $221.53M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.97 |
| 52-Week Low | $4.15 |
| Volume | 150 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover HELP: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.75.